EMERGENT BIOSOLUTIONS INC. Retained Earnings
EMERGENT BIOSOLUTIONS INC. (EBS) had Retained Earnings of -$333.20 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$333.20M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$153.00M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$159.80M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$105.20M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$333.20M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$153.00M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | -$159.80M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$105.20M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | -$156.40M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$144.40M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$212.40M 10-K · filed 2026-02-27 | |
| 2024-09-30 | -$181.10M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$295.90M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | -$12.80M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | -$21.80M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $27.70M 10-Q · filed 2023-12-11 | |
| 2023-06-30 | $289.70M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $551.00M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $738.70M 10-K · filed 2024-03-08 | $734.00M 10-K · filed 2023-03-01 |
| 2022-09-30 | $805.70M 10-Q · filed 2023-12-11 | $822.00M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $897.70M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $954.10M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $950.30M 10-K/A · filed 2023-12-11 | $957.80M 10-K · filed 2022-02-25 |
| 2021-09-30 | $768.50M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $801.20M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $796.60M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $726.90M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $541.50M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $502.00M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $409.30M 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $421.80M 10-K · filed 2021-02-19 | |
| 2019-09-30 | $374.90M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $331.70M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $341.30M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $367.30M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $370.73M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $349.78M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $299.64M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $337.10M 10-K · filed 2019-02-22 | $337.07M 10-K · filed 2018-02-23 |
| 2017-09-30 | $303.13M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $269.58M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $264.96M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $254.48M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $214.69M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $344.18M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $355.13M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $351.14M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $317.79M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $280.85M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $266.75M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $288.27M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $258.15M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $236.32M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $231.29M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $251.53M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $236.31M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $222.81M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $212.33M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $220.39M 10-K · filed 2014-03-10 | |
| 2012-09-30 | $204.29M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $197.67M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $190.04M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $196.87M 10-K · filed 2013-03-08 | |
| 2011-09-30 | $168.21M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $166.66M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $173.85M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |